Unknown

Dataset Information

Functional activation of the AKT-mTOR signalling axis in a real-world metastatic breast cancer cohort.


ABSTRACT:

Background

Mutations of the PIK3CA/AKT/mTOR axis are common events in metastatic breast cancers (MBCs). This study was designed to evaluate the extent to which genetic alterations of the PIK3CA/AKT/mTOR can predict protein activation of this signalling axis in MBCs.

Methods

Molecular profiles were generated by CLIA-certified laboratories from a real-world evidence cohort of 171 MBC patients. Genetic alterations of the PIK3CA pathway were measured using next-generation sequencing. Activation levels of AKT and downstream signalling molecules were quantified using two orthogonal proteomic methods. Protein activity was correlated with underlying genomic profiles and response to CDK4/6 inhibition in combination with endocrine treatment (ET).

Results

Oncogenic alterations o

SUBMITTER: Prasad D 

PROVIDER: S-EPMC11519601 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature